在癌症免疫治疗中mRNA疫苗的进展和前景
Yixuan Liu1, Qijia Yan2, Zhaoyang Zeng1
1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China; Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, China.
Biochimica et biophysica acta. Reviews on cancer
|January 3, 2024
概括
使者RNA (mRNA) 疫苗代表了癌症免疫治疗的前沿,提供了高安全性和有效性. 技术的进步正在克服以前的局限性,为癌症治疗的快速发展铺平了道路.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 癌症疫苗的目的是利用免疫系统对抗瘤.
- 传统的疫苗 (瘤病毒,细胞,,核酸) 是有前途的,但面临着局限性.
- 使者RNA (mRNA) 疫苗正在成为癌症免疫疗法的强大工具.
研究的目的:
- 为癌症提供mRNA疫苗技术的概述.
- 突出癌症mRNA疫苗的机制,临床进展和未来前景.
- 讨论mRNA疫苗与免疫检查点抑制剂的协同潜力.
主要方法:
- 关于癌症mRNA疫苗的当前文献的综述.
- 对技术进步的分析,使mRNA疫苗的开发成为可能 (例如,伪尿素修饰).
- 检查临床试验数据和组合疗法.
主要成果:
- mRNA疫苗显示出高安全性,易于生产和有效性.
- 技术改进解决了不稳定性和交付等挑战.
- 临床试验显示出有希望的结果,特别是与免疫检查点抑制剂 (ICI) 结合使用时.
结论:
- 在癌症免疫治疗中,mRNA疫苗正在迅速发展.
- 预计在不久的将来将进一步开发和临床应用.
- 与ICI结合的策略可以增强抗瘤免疫反应.
相关概念视频
Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K


